Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.152 USD | -41.20% | -49.40% | -2.97% |
17/05 | Jaguar Health Plans 1-for-60 Reverse Split Next Week | MT |
14/05 | Earnings Flash (JAGX) JAGUAR HEALTH Reports Q1 Revenue $2.4M, vs. Street Est of $3M | MT |
Sales 2024 * | 1.51Cr 125.81Cr | Sales 2025 * | 2.27Cr 188.67Cr | Capitalization | 7.14Cr 594.51Cr |
---|---|---|---|---|---|
Net income 2024 * | -2.6Cr -216.48Cr | Net income 2025 * | -2.1Cr -174.85Cr | EV / Sales 2024 * | 4.73 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.15 x |
P/E ratio 2024 * |
-2.87
x | P/E ratio 2025 * |
-3.69
x | Employees | 49 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.62% |
Latest transcript on Jaguar Health, Inc.
1 day | -41.20% | ||
1 week | -49.40% | ||
Current month | -31.58% | ||
1 month | -18.34% | ||
3 months | +108.66% | ||
6 months | -68.20% | ||
Current year | -2.97% |
Managers | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 06/13/06 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 01/19/01 |
Chief Tech/Sci/R&D Officer | 60 | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 06/13/06 |
James Bochnowski
CHM | Chairman | 80 | 01/14/01 |
John Micek
BRD | Director/Board Member | 71 | 01/16/01 |
Date | Price | Change | Volume |
---|---|---|---|
20/24/20 | 0.1466 | -43.29% | 18 798 466 |
17/24/17 | 0.2585 | -9.84% | 58,064,970 |
16/24/16 | 0.2867 | +12.39% | 31,266,489 |
15/24/15 | 0.2551 | -7.20% | 25,164,148 |
14/24/14 | 0.2749 | -5.30% | 63,969,137 |
Delayed Quote Nasdaq, May 20, 2024 at 07:25 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.97% | 7.14Cr | |
+9.60% | 11TCr | |
+11.69% | 11TCr | |
-2.50% | 2.2TCr | |
-14.10% | 2.19TCr | |
-5.29% | 1.92TCr | |
-4.05% | 1.81TCr | |
-38.29% | 1.77TCr | |
+7.13% | 1.43TCr | |
+35.68% | 1.24TCr |
- Stock Market
- Equities
- JAGX Stock